Synaptogenix Inc (SNPX)

Synaptogenix Inc Aktie (SNPX) Neueste Nachrichten

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

MSN

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

MSN

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

MSN

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

MSN

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for ... - Investing.com India

Investing.com India

Synaptogenix regains Nasdaq listing compliance By Investing.com - Investing.com

Investing.com

Synaptogenix increases psilocybin stake with PsygaBio - Green Market Report

Green Market Report

What's Going On With Synaptogenix (SNPX) Stock? - Synaptogenix (NASDAQ:SNPX) - Benzinga

Benzinga

Synaptogenix announces reverse stock split to regain Nasdaq compliance - Investing.com

Investing.com

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Benzinga

Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why Sintx Technologies Shares Are Trading Higher By Over 39%; Here Are 20 Stocks Moving Premarket

Benzinga

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

InvestorPlace

Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age ... - PR Newswire

PR Newswire

Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of ... - PR Newswire

PR Newswire

Synaptogenix trial - 'extremely important' outcome for Alzheimer's - OutSourcing-Pharma.com

OutSourcing-Pharma.com

Advanced Alzheimer's: Bryostatin-1 may be safe, effective - Medical News Today

Medical News Today

Bryostatin found to slow cognitive decline in advanced Alzheimer's... - Alzheimer's News Today

Alzheimer's News Today

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.31% - Investing.com India

Investing.com India

In lab model of ALS, bryostatin-1 boosts cell survival | ALS News... - ALS News Today

ALS News Today

Best Penny Stocks To Buy Now? 3 Under $1 To Watch - Penny Stocks

Penny Stocks

Phase 1 trial of bryostatin-1 in MS expected by year's end |... - Multiple Sclerosis News Today

Multiple Sclerosis News Today

Synaptogenix reports data from Phase II Alzheimer's trial - Clinical Trials Arena

Clinical Trials Arena

Why Is Synaptogenix (SNPX) Stock Plummeting 70% Today? - InvestorPlace

InvestorPlace

Synaptogenix (SNPX): Bryostatin For Alzheimer's, As Binary As Can Be - Seeking Alpha

Seeking Alpha

Synaptogenix Closes $15 Million Private Placement - citybiz

citybiz

Theriva Biologics Stock (AMEX:TOVX), Quotes and News Summary - Benzinga

Benzinga

Investor pleads guilty to insider trading in Alzheimer's biotech - Fierce Biotech

Fierce Biotech

Clinical Catch-Up: Prometheus, Algernon, Seelos, Inozyme and Takeda - BioSpace

BioSpace

Synaptogenix concludes subject enrolment in Phase IIb Alzheimer's trial - Clinical Trials Arena

Clinical Trials Arena

Synaptogenix Inc (NASDAQ: SNPX) Announces a Peer-reviewed Paper on Bryostatin - BP Journal

BP Journal

Synaptogenix Inc. (NASDAQ: SNPX) Announce Publication of Peer-Reviewed Data of Bryostatin Study in AD in Journal ... - BP Journal

BP Journal

Synaptogenix (SNPX) Stock Price, News & Analysis - MarketBeat

MarketBeat

Alzamend Neuro Stock (NASDAQ:ALZN), Quotes and News Summary - Benzinga

Benzinga

Neurotrope completes formation of new company Synaptogenix - NeuroNews International

NeuroNews International